In human hepatic organoids, Mdivi-1 mitigated the alcohol-produced mitochondrial retrograde signaling and hepatic steatosis via DRP1 inhibition (Angireddy et al., 2020). This evidence concerns the gene DNM1L and fatty liver disease.